Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)
NCT03124654 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2017-08-03
Summary
Pharmacists are in the best position to counsel and educate patients on anticoagulant agents such as NOACs. This should enable patients to play a more active role in their treatment and ultimately enhance adherence behaviour. However, educational elements should be targeted to knowledge. Thus, the investigators will develop and validate a questionnaire that can assess knowledge about NOACs
Conditions
- Atrial Fibrillation
- Pulmonary Embolism
- Deep Vein Thrombosis
Interventions
- BEHAVIORAL
-
Education
Patients will receive several questionnaires to fill in. Knowledge about NOACs will be assessed with a newly developped questionnaire and an educational program will be dispensed while analysing the answers (reactive educational program).
Sponsors & Collaborators
-
University of Basel
collaborator OTHER -
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Kurt Hersberger, Prof. · University of Basel
-
Isabelle Arnet, PD. · Pharmaceutical Care Research Group, University of Base
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2017-07-30
- Completion
- 2017-07-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Education Program for Patients Receiving Oral Anticoagulation
NCT01339611 ·Status: UNKNOWN ·Phase: NA
-
Patient Training About the Safety of Warfarin Therapy
NCT02757482 ·Status: COMPLETED ·Phase: NA
-
Anticoagulation Preference by AF Patients Study
NCT02607371 ·Status: COMPLETED
-
Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme
NCT01809015 ·Status: COMPLETED
-
Evaluataion of NOAC Levels in Acute Stroke
NCT06144866 ·Status: RECRUITING
-
Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study
NCT02876718 ·Status: COMPLETED
-
Precision Medicine Platform for Novel Oral Anticoagulants
NCT04056143 ·Status: UNKNOWN
-
Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients
NCT06187155 ·Status: RECRUITING ·Phase: NA
-
Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients
NCT02925247 ·Status: COMPLETED ·Phase: NA
-
Excessive Warfarin Anticoagulation - Causes and Consequences
NCT02761941 ·Status: UNKNOWN
-
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
NCT05825573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Pilot Study: Comparison of Patients' Knowledge of Direct Oral Anticoagulants in Post-hospitalization Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview During Hospitalization
NCT04674202 ·Status: UNKNOWN
-
Effectiveness of a Multidisciplinary Medication Review With Follow-up for Patients Treated With Coumarin Anticoagulants in Primary Care
NCT03154489 ·Status: COMPLETED ·Phase: NA
-
Factors Associated to the Instability of the INR (International Normalized Ratio ) in the Prevention of Thromboembolism AVK (Anti Vitamin K) in Atrial Fibrillation in the Elderly: Instead of Comorbidities
NCT02841475 ·Status: COMPLETED
-
Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation
NCT03666962 ·Status: UNKNOWN
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
NCT02906527 ·Status: UNKNOWN
-
Subtherapeutic INR Levels in Patients With AVK: Incidence, Associated Factors, Prognosis and Control Strategies
NCT02610153 ·Status: COMPLETED
-
Patient Convenience Study
NCT02597920 ·Status: COMPLETED
-
A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage
NCT03189069 ·Status: COMPLETED
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
NCT02286414 ·Status: COMPLETED
-
PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
NCT00377143 ·Status: WITHDRAWN ·Phase: PHASE4
-
Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA
NCT02657616 ·Status: COMPLETED
-
Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
NCT04249401 ·Status: COMPLETED
-
Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon
NCT03563937 ·Status: COMPLETED